Home/Filings/4/0001600132-18-000099
4//SEC Filing

Luehring Jens 4

Accession 0001600132-18-000099

CIK 0001600132other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 4:32 PM ET

Size

4.5 KB

Accession

0001600132-18-000099

Insider Transaction Report

Form 4
Period: 2018-06-21
Luehring Jens
Director10% Owner
Transactions
  • Award

    Common Stock

    2018-06-21+14,55595,213 total

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001631764

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:32 PM ET
Size
4.5 KB